Dyne Therapeutics Inc. (DYN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
13.30
-0.92 (-6.47%)
At close: Sep 08, 2025, 3:59 PM
13.30
0.00%
After-hours: Sep 08, 2025, 04:20 PM EDT

Dyne Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
2.24M 2.46M 3.35M 1.09M
Gross Profit
-2.24M -2.46M -3.35M -1.09M
Operating Income
-343.89M -242.16M -170.96M -150.03M
Interest Income
26.92M 7.64M 2.92M 742K
Pretax Income
-317.42M -235.94M -168.1M -149.29M
Net Income
-317.42M -235.94M -165.24M -149.28M
Selling & General & Admin
62.48M 31.4M 28.2M 28.72M
Research & Development
281.41M 210.76M 142.76M 121.31M
Other Expenses
-2.24M -2.46M n/a n/a
Operating Expenses
341.64M 239.7M 170.96M 150.03M
Interest Expense
n/a n/a 2.92M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
343.89M 242.16M 170.96M 150.03M
Income Tax Expense
n/a n/a -2.86M -8K
Shares Outstanding (Basic)
94.14M 59.68M 51.98M 50.9M
Shares Outstanding (Diluted)
94.14M 59.68M 51.98M 50.9M
EPS (Basic)
-3.37 -3.95 -3.23 -2.93
EPS (Diluted)
-3.37 -3.95 -3.23 -2.93
EBITDA
-315.18M -233.48M -164.75M -148.2M
EBIT
-317.42M -235.94M -168.1M -149.29M
Depreciation & Amortization
2.24M 2.46M 3.35M 1.09M